Unique ID issued by UMIN | UMIN000019136 |
---|---|
Receipt number | R000022126 |
Scientific Title | Procalcitonin (PCT) levels and postoperative complications in the scheduled surgery patients; a prospective observational study |
Date of disclosure of the study information | 2015/10/01 |
Last modified on | 2024/05/19 19:48:34 |
Procalcitonin (PCT) levels and postoperative complications in the scheduled surgery patients; a prospective observational study
Procalcitonin (PCT) levels in the scheduled surgery patients
Procalcitonin (PCT) levels and postoperative complications in the scheduled surgery patients; a prospective observational study
Procalcitonin (PCT) levels in the scheduled surgery patients
Japan |
Scheduled surgery patients
Surgery in general | Obstetrics and Gynecology | Dermatology |
Orthopedics | Urology | Anesthesiology |
Oral surgery | Neurosurgery | Cardiovascular surgery |
Plastic surgery | Aesthetic surgery | Intensive care medicine |
Malignancy
NO
To detect relation between levels of PCT and postoperative complications in scheduled surgery patients depending on operative procedure
Others
To detect influencing factors of levels of PCT
Confirmatory
Comparison between PCT levels of Day 1 and with or without postoperative complication, depending on operative procedure
1) Comparison between PCT and other data as for detecting complications
(2) Evaluation of PCT levels according to severity of disease
(3) Analysis of influencing factors of PCT levels
(4) Relation between survival rate (at Day 28, 60, and 90) and PCT level
(5) Time course of changes in PCT levels
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Scheduled surgery patients who candidates surgical ICU admission
(1) Predict infectious disease before surgery.
(2) Patients who are exposed to infection factor during the operation.
(3) Emergency surgical patients.
(4) Patients who are judged as inappropriate candidates for the trial by the investigators on preoperative anesthetic consultation.
3000
1st name | Yoshihito |
Middle name | |
Last name | Fujita |
Aichi Medical University School of Medicine
Department of Anesthesiology
480-1195
1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan
+81-561-62-3311
fujita.yoshihito.823@mail.aichi-med-u.ac.jp
1st name | Yoshihito |
Middle name | |
Last name | Fujita |
Aichi Medical University School of Medicine
Department of Anesthesiology
480-1195
1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan
+81-561-62-3311
fujita.yoshihit.823@mail.aichi-med-u.ac.jp
Aichi Medical University School of Medicine, Department of Anesthesiology
None
Self funding
Aichi Medical University IRB
1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan
+81-561-3311
kanrika@aichi-med-u.ac.jp
NO
2015 | Year | 10 | Month | 01 | Day |
https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi
Unpublished
https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi
1900
Until now on 24 April 2021, we could show these preliminary outcomes. We tried to show the detail outcomes as soon as possible. As for about 1900 patients, the patients with late complications had higher level of procalcitonin (PCT). In addition, the cutoff of 0.5 ng/ml of PCT was useful for detecting the late complications after non-cardiac surgeries.
2021 | Year | 04 | Month | 24 | Day |
The study was designed as a single-center, prospective, cohort, observational study. All patients scheduled for non-cardiac surgery between December 2015 and March 2017 at our University were screened for the participants.
Before starting to gather patients for inclusion, we picked up optimal surgeries for our study because some surgical procedures do not lead increase of PCT . We chose and investigated the patients of general gastroenterological surgery, thoracic surgery, gynecology, and urology. Therefore, the inclusion criterion was elective general gastroenterological surgery, thoracic surgery, gynecology, and urology. Exclusion criteria comprised: age <18 years, refusal to participate, surgeries suspected of infections, the patients who were exposed to infection factor during the surgery, urgent surgeries and the surgeries except for the upper inclusion surgeries such as cardiac surgery, brain surgery, orthopedic surgery, vascular surgery, breast surgery, cesarean section, endocrine surgery, plastic surgery, ear, nose and throat surgery, and kidney transplant surgery.
This is an observational study. Adverse events were none.
Until now on 24 April 2021, we could show these preliminary outcomes, briefly. We tried to show the detail outcomes as soon as possible. As for about 1900 patients, the patients with late complications had higher level of procalcitonin (PCT). In addition, the cutoff of 0.5 ng/ml of PCT was useful for detecting the late complications after non-cardiac surgeries.
No longer recruiting
2015 | Year | 09 | Month | 28 | Day |
2015 | Year | 11 | Month | 24 | Day |
2015 | Year | 12 | Month | 01 | Day |
2019 | Year | 12 | Month | 31 | Day |
2019 | Year | 12 | Month | 31 | Day |
2019 | Year | 12 | Month | 31 | Day |
2022 | Year | 12 | Month | 31 | Day |
Cohort study
Recruitment: all eligible post-operative patients who were sequentially admitted to the general ICU of Aichi Medical University Hospital for 12 months, from January 2016 to December 2016.
Measurement item: PCT,CRP, WBC, body temperature, postoperative complication and so on.
2015 | Year | 09 | Month | 28 | Day |
2024 | Year | 05 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022126